taurine has been researched along with Fatty Liver in 26 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study elucidated the effect of taurine on fatty liver in simple obesity." | 9.08 | Effect of taurine on the fatty liver of children with simple obesity. ( Hayashi, M; Maruyama, T; Nittono, H; Obinata, K; Watanabe, T, 1996) |
| "This study shows that preconditioning with taurine or glycine is equally effective in preventing injury to fatty livers most likely via Kupffer cell-dependent mechanisms." | 7.77 | Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study. ( Bruns, H; Büchler, MW; Flechtenmacher, C; Galli, U; Gebhard, MM; Schemmer, P; Schulze-Bergkamen, H; Watanpour, I; Zorn, M, 2011) |
| "Our objective was to explore the restorative effect of taurine on experimental nonalcoholic steatohepatitis (NASH)." | 7.73 | The restorative effect of taurine on experimental nonalcoholic steatohepatitis. ( Chen, SW; Chen, YX; Lin, Y; Shi, J; Xie, WF, 2006) |
| "Non-alcoholic fatty liver disease (NAFLD) has several phases of flow: from simple steatosis, steatohepatitis, and ending with fibrosis and cirrhosis." | 6.75 | [Taurine in the treatment of non-alcoholic fatty liver disease]. ( Elizarova, EP; Nilova, TV; Noskova, KK; Ovsiannikova, ON; Zvenigorodskaia, LA, 2010) |
| "This study elucidated the effect of taurine on fatty liver in simple obesity." | 5.08 | Effect of taurine on the fatty liver of children with simple obesity. ( Hayashi, M; Maruyama, T; Nittono, H; Obinata, K; Watanabe, T, 1996) |
| "This study shows that preconditioning with taurine or glycine is equally effective in preventing injury to fatty livers most likely via Kupffer cell-dependent mechanisms." | 3.77 | Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study. ( Bruns, H; Büchler, MW; Flechtenmacher, C; Galli, U; Gebhard, MM; Schemmer, P; Schulze-Bergkamen, H; Watanpour, I; Zorn, M, 2011) |
| "Our objective was to explore the restorative effect of taurine on experimental nonalcoholic steatohepatitis (NASH)." | 3.73 | The restorative effect of taurine on experimental nonalcoholic steatohepatitis. ( Chen, SW; Chen, YX; Lin, Y; Shi, J; Xie, WF, 2006) |
| "Rats were treated with a hepatotoxin thioacetamide (TAA) and examined 21 days later, when they showed moderate fatty metamorphosis of the liver and morphological changes in brain indicative of excitotoxic neuronal damage, but no evident biochemical or neurophysiological symptoms of hepatic encephalopathy (HE)." | 3.70 | Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. ( Albrecht, J; Borkowska, HD; Gadamski, R; Hilgier, W; Oja, SS; Saransaari, P; Walski, M; Zielińska, M, 1999) |
| "Non-alcoholic fatty liver disease (NAFLD) has several phases of flow: from simple steatosis, steatohepatitis, and ending with fibrosis and cirrhosis." | 2.75 | [Taurine in the treatment of non-alcoholic fatty liver disease]. ( Elizarova, EP; Nilova, TV; Noskova, KK; Ovsiannikova, ON; Zvenigorodskaia, LA, 2010) |
| "Non-alcoholic fatty liver disease (NAFLD) is the commonest form of chronic liver disease in developed countries." | 1.40 | Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis. ( Azuma, T; Hoshi, N; Kawano, Y; Minami, A; Nishiumi, S; Terashima, Y; Yoshida, M, 2014) |
| "Taurine is a conditionally essential amino acid in humans that may be a promising therapy for treating this disease." | 1.38 | The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio). ( da Rosa, DP; da Silveira, TR; Escobar, TD; Fracasso, LB; Hammes, TO; Hartmann, CR; Marroni, NP; Pedroso, GL; Porawski, M, 2012) |
| "Lidocaine metabolism was found to be impaired in groups PN, T15, and T50." | 1.29 | Effects of taurine supplementation in parenteral nutrition-associated hepatosteatosis and lidocaine metabolism. A study using isolated rat liver perfusion. ( Coutts, RT; Jewell, LD; Tam, YK; Zaman, N, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.54) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 4 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, M | 1 |
| Funaki, A | 1 |
| Fukuhara, C | 1 |
| Sumiya, Y | 1 |
| Sugiura, Y | 1 |
| Blachier, F | 1 |
| Andriamihaja, M | 1 |
| Blais, A | 1 |
| Grevengoed, TJ | 1 |
| Trammell, SA | 1 |
| Svenningsen, JS | 1 |
| Makarov, MV | 1 |
| Nielsen, TS | 1 |
| Jacobsen, JCB | 1 |
| Treebak, JT | 1 |
| Calder, PC | 1 |
| Migaud, ME | 1 |
| Cravatt, BF | 1 |
| Gillum, MP | 1 |
| Stachowicz, A | 1 |
| Wiśniewska, A | 1 |
| Kuś, K | 1 |
| Białas, M | 1 |
| Łomnicka, M | 1 |
| Totoń-Żurańska, J | 1 |
| Kiepura, A | 1 |
| Stachyra, K | 1 |
| Suski, M | 1 |
| Bujak-Giżycka, B | 1 |
| Jawień, J | 1 |
| Olszanecki, R | 1 |
| Suzuki, Y | 1 |
| Kaneko, R | 1 |
| Nomura, M | 1 |
| Naito, H | 1 |
| Kitamori, K | 1 |
| Nakajima, T | 1 |
| Ogawa, T | 1 |
| Hattori, H | 1 |
| Seno, H | 1 |
| Ishii, A | 1 |
| Yang, KT | 2 |
| Lin, C | 1 |
| Liu, CW | 1 |
| Chen, YC | 2 |
| Terashima, Y | 1 |
| Nishiumi, S | 1 |
| Minami, A | 1 |
| Kawano, Y | 1 |
| Hoshi, N | 1 |
| Azuma, T | 1 |
| Yoshida, M | 1 |
| Branco, RC | 1 |
| Batista, TM | 1 |
| Camargo, RL | 1 |
| Borck, PC | 1 |
| Ribeiro, RA | 1 |
| Zoppi, CC | 1 |
| Lollo, PC | 1 |
| Morato, PN | 1 |
| Boschero, AC | 1 |
| Carneiro, EM | 1 |
| Chen, X | 1 |
| Sebastian, BM | 1 |
| Tang, H | 1 |
| McMullen, MM | 1 |
| Axhemi, A | 1 |
| Jacobsen, DW | 1 |
| Nagy, LE | 2 |
| Yang, L | 1 |
| Latchoumycandane, C | 1 |
| McMullen, MR | 1 |
| Pratt, BT | 1 |
| Zhang, R | 1 |
| Papouchado, BG | 1 |
| Feldstein, AE | 1 |
| McIntyre, TM | 1 |
| Zvenigorodskaia, LA | 1 |
| Ovsiannikova, ON | 1 |
| Noskova, KK | 1 |
| Nilova, TV | 1 |
| Elizarova, EP | 1 |
| Yang, JS | 1 |
| Kim, JT | 1 |
| Jeon, J | 1 |
| Park, HS | 1 |
| Kang, GH | 1 |
| Park, KS | 1 |
| Lee, HK | 1 |
| Kim, S | 1 |
| Cho, YM | 1 |
| Chang, YY | 1 |
| Chou, CH | 1 |
| Chiu, CH | 1 |
| Lin, YL | 1 |
| Weng, WL | 1 |
| Bruns, H | 1 |
| Watanpour, I | 1 |
| Gebhard, MM | 1 |
| Flechtenmacher, C | 1 |
| Galli, U | 1 |
| Schulze-Bergkamen, H | 1 |
| Zorn, M | 1 |
| Büchler, MW | 1 |
| Schemmer, P | 1 |
| Li, H | 1 |
| Wang, L | 1 |
| Yan, X | 1 |
| Liu, Q | 1 |
| Yu, C | 1 |
| Wei, H | 1 |
| Li, Y | 1 |
| Zhang, X | 1 |
| He, F | 1 |
| Jiang, Y | 1 |
| Gentile, CL | 1 |
| Nivala, AM | 1 |
| Gonzales, JC | 1 |
| Pfaffenbach, KT | 1 |
| Wang, D | 1 |
| Wei, Y | 1 |
| Jiang, H | 1 |
| Orlicky, DJ | 1 |
| Petersen, DR | 1 |
| Pagliassotti, MJ | 1 |
| Maclean, KN | 1 |
| Hammes, TO | 1 |
| Pedroso, GL | 1 |
| Hartmann, CR | 1 |
| Escobar, TD | 1 |
| Fracasso, LB | 1 |
| da Rosa, DP | 1 |
| Marroni, NP | 1 |
| Porawski, M | 1 |
| da Silveira, TR | 1 |
| Chen, SW | 2 |
| Chen, YX | 2 |
| Zhang, XR | 1 |
| Zeng, X | 1 |
| Liu, S | 1 |
| Xie, WF | 2 |
| Shi, J | 1 |
| Lin, Y | 1 |
| Zaman, N | 1 |
| Tam, YK | 1 |
| Jewell, LD | 1 |
| Coutts, RT | 1 |
| Obinata, K | 1 |
| Maruyama, T | 1 |
| Hayashi, M | 1 |
| Watanabe, T | 1 |
| Nittono, H | 1 |
| Kerai, MD | 1 |
| Waterfield, CJ | 1 |
| Kenyon, SH | 1 |
| Asker, DS | 1 |
| Timbrell, JA | 1 |
| Hilgier, W | 1 |
| Zielińska, M | 1 |
| Borkowska, HD | 1 |
| Gadamski, R | 1 |
| Walski, M | 1 |
| Oja, SS | 1 |
| Saransaari, P | 1 |
| Albrecht, J | 1 |
| Cantafora, A | 1 |
| Mantovani, A | 1 |
| Masella, R | 1 |
| Mechelli, L | 1 |
| Alvaro, D | 1 |
| Borgman, RF | 1 |
| Haselden, FH | 1 |
| Sherr, HP | 1 |
| Nair, PP | 1 |
| White, JJ | 1 |
| Banwell, JG | 1 |
| Lockwood, DH | 1 |
1 review available for taurine and Fatty Liver
| Article | Year |
|---|---|
Sulfur-Containing Amino Acids and Lipid Metabolism.
Topics: Amino Acids, Sulfur; Animals; Atherosclerosis; Betaine; Cholesterol; Cysteine; Dietary Proteins; Die | 2020 |
2 trials available for taurine and Fatty Liver
| Article | Year |
|---|---|
[Taurine in the treatment of non-alcoholic fatty liver disease].
Topics: Adult; Aged; Fatty Liver; Female; Humans; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Diseas | 2010 |
Effect of taurine on the fatty liver of children with simple obesity.
Topics: Adolescent; Alanine Transaminase; Child; Cholesterol; Diet, Reducing; Fatty Liver; Humans; Liver; Li | 1996 |
23 other studies available for taurine and Fatty Liver
| Article | Year |
|---|---|
Taurine attenuates hepatic steatosis in a genetic model of fatty liver disease.
Topics: Acetyl-CoA Carboxylase; Animals; Disease Models, Animal; Fatty Liver; Female; Glutathione Transferas | 2020 |
An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides.
Topics: Amidohydrolases; Animals; Bile; Disease Models, Animal; Docosahexaenoic Acids; Fatty Acids, Omega-3; | 2021 |
Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Diet, H | 2021 |
Simple and rapid quantitation of 21 bile acids in rat serum and liver by UPLC-MS-MS: effect of high fat diet on glycine conjugates of rat bile acids.
Topics: Animals; Bile Acids and Salts; Biomarkers; Calibration; Cholesterol, Dietary; Chromatography, Liquid | 2013 |
Effects of chicken-liver hydrolysates on lipid metabolism in a high-fat diet.
Topics: Animals; Antioxidants; Carnosine; Chickens; Cricetinae; Diet, High-Fat; Dietary Fats; Dietary Protei | 2014 |
Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis.
Topics: Animals; Choline; Diet; Fatty Liver; Liver; Liver Cirrhosis; Male; Metabolome; Methionine; Mice, Inb | 2014 |
Long-term taurine supplementation leads to enhanced hepatic steatosis, renal dysfunction and hyperglycemia in mice fed on a high-fat diet.
Topics: Adiposity; Animals; Blood Glucose; Body Weight; Diet, High-Fat; Fatty Liver; Hyperglycemia; Kidney D | 2015 |
Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats.
Topics: Adiponectin; Adipose Tissue; Animals; Cytokines; Dietary Supplements; Ethanol; Fatty Liver; Liver; O | 2009 |
Chronic alcohol exposure increases circulating bioactive oxidized phospholipids.
Topics: Administration, Oral; Alcoholism; Animals; Diet; Ethanol; Fatty Liver; Feeding Behavior; Humans; Liv | 2010 |
Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice.
Topics: Administration, Oral; Amino Acids; Animals; Blotting, Western; Carbohydrate Metabolism; Cluster Anal | 2010 |
Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit.
Topics: Animals; Cholesterol, Dietary; Cricetinae; Dietary Fats; Disease Models, Animal; Fatty Liver; Gene E | 2011 |
Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study.
Topics: Animals; Cell Communication; Clinical Enzyme Tests; Fatty Liver; Female; Glycine; Kupffer Cells; Mic | 2011 |
A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.
Topics: Adult; Animals; Biomarkers; Blood Glucose; Diet; Fatty Liver; Female; Glutamic Acid; Humans; Lactic | 2011 |
Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.
Topics: Animals; Cell Death; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Diet; Endoplasmic Ret | 2011 |
The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio).
Topics: Animals; Disease Models, Animal; Fatty Liver; Female; Lipid Metabolism; Lipid Peroxidation; Liver; M | 2012 |
[The prevention and therapeutic effect of taurine on experimental rat nonalcoholic fatty livers].
Topics: Animals; Fatty Liver; Liver; Male; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Taurine | 2006 |
The restorative effect of taurine on experimental nonalcoholic steatohepatitis.
Topics: Adiponectin; Animals; Blood Glucose; Body Weight; Fatty Liver; Glucose; Hepatitis; Lipid Peroxidatio | 2006 |
Effects of taurine supplementation in parenteral nutrition-associated hepatosteatosis and lidocaine metabolism. A study using isolated rat liver perfusion.
Topics: Amino Acids; Animals; Fatty Liver; Food, Formulated; Lidocaine; Liver; Liver Function Tests; Male; P | 1996 |
Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adenosine Triphosphate; Alcoholism; Anima | 1998 |
Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure.
Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Biological Transport; Corpus Striatum; Excitatory Amin | 1999 |
Effect of taurine administration on liver lipids in guinea pig.
Topics: Animals; Body Weight; Fatty Liver; Glycerides; Guinea Pigs; Lipid Metabolism; Liver; Male; Organ Siz | 1986 |
Cholelithiasis in rabbits: effects of bile constituents and hormones on dissolution of gallstones.
Topics: Adrenocorticotropic Hormone; Animals; Bile Acids and Salts; Cholelithiasis; Cortisone; Fatty Liver; | 1969 |
Bile acid metabolism and hepatic disease following small bowel bypass for obesity.
Topics: Adult; Bile; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; | 1974 |